The Simpson Querrey Center for Epigenetics is connecting the Northwestern academic and medical community to integrate the study of epigenetics into science and clinical care.
Metformin, an inexpensive diabetes drug, has been found to reduce the risk of heart attacks and strokes triggered by air pollution by reducing inflammation in the lungs that triggers clotting.
A new study finds that excessive carbon dioxide in a patient’s bloodstream can lead to a restricted airway, calling into question current clinical practices for patients with chronic obstructive pulmonary disease.
A team of scientists has uncovered the precise cells that flow into and harm the lung soon after a transplant. The study, published in The Journal of Clinical Investigation, may lead to drug therapies that target the destructive cells.
Northwestern Medicine scientists identified a complex regulatory system that keeps cells functioning when their oxygen supply is cut off.
Two Northwestern Medicine clinical trials investigated drugs to treat patients suffering from vasodilatory shock and respiratory failure, showing promising results.
Patients with advanced neuroendocrine tumors had a similar quality of life while on a newly approved chemotherapy drug, as compared to patients receiving a placebo, according to a Northwestern Medicine study.
Northwestern Medicine scientists have published a paper in Nature Chemical Biology, detailing an innovative use of CRISPR-Cas9 technology that has helped reveal how oxidative stress explains a common herbicide’s link to risk of Parkinson’s.
Northwestern Medicine scientists have discovered that a unique population of immune cells play a key role in the development of pulmonary fibrosis, a fatal lung disease.
Northwestern Medicine scientists have discovered the mechanism that drives primary lung allograft dysfunction, the leading cause of death after lung transplantation.